मुख्यपृष्ठ › फुफ्फुसाचा कॅन्सर › इलिनॉय › Chicago
Chicago, IL मधील फुफ्फुसाचा कॅन्सर साठी क्लिनिकल ट्रायल्स
Chicago आणि आजूबाजूच्या ठिकाणी (सुमारे 30 मैलांच्या आत) फुफ्फुसाचा कॅन्सर साठी 41 अभ्यास सहभागी शोधत आहेत. कोण सहभागी होऊ शकते आणि अभ्यास संघाशी संपर्क कसा साधावा हे पाहण्यासाठी अभ्यास उघडा.
अधिकृत अभ्यास मजकूर (इंग्रजी)
अभ्यासासाठी सहभागी शोधत आहात? हे पृष्ठ शीर्षस्थानी दर्शवा — 30 दिवसांसाठी $99 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
निवड सुरू आहेफेज 3
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- आणि आणखी 1
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
निवड सुरू आहेनिरीक्षण अभ्यासस्वस्थ स्वयंसेवकांचे स्वागत आहे
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- आणि आणखी 1
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
निवड सुरू आहेफेज 1/2
- University of Illinois Hospital & Health Sciences System ( Site 0044), Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
निवड सुरू आहेफेज 2
- University of Illinois Cancer Center, Chicago
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
निवड सुरू आहेफेज 3
- Rush MD Anderson Cancer Center, Chicago
- University of Illinois, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
निवड सुरू आहेफेज 3
- Northwestern University, Chicago
- University of Illinois, Chicago
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
निवड सुरू आहेफेज 3
- Northwestern University, Chicago
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
निवड सुरू आहेफेज 3
- University of Illinois Cancer Center, Chicago
- Center for Care and Discovery, Chicago
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
निवड सुरू आहेफेज 3
- University of Illinois Hospital and Health Sciences System (Outpatient Cancer Center), Chicago
- University of Illinois Hospital and Health Sciences System, Chicago
- Illinois Cancer Specialists, Chicago
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
निवड सुरू आहेफेज 3
- University of Illinois Chicago, Chicago
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
निवड सुरू आहेफेज 2
- Rush University Medical Center, Chicago
- University of Illinois Chicago, Chicago
A Registry for People With Lung Cancer
निवड सुरू आहेनिरीक्षण अभ्यास
- Rush University Medical Center (Data collection only), Chicago
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
निवड सुरू आहेफेज 2
- Research Site, Chicago
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
निवड सुरू आहेफेज 2/3
- Rush University Medical Center, Chicago
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
निवड सुरू आहेफेज 1/2
- University of Chicago Comprehensive Cancer Center, Chicago
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
निवड सुरू आहेफेज 1
- University of Illinois Cancer Center, Chicago
- University of Chicago Medicine, Chicago
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
निवड सुरू आहेफेज 3
- University of Illinois at Chicago, Chicago
- University of Chicago Hospital, Chicago
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
निवड सुरू आहेफेज 3
- University of Illinois Hospital and Health Sciences Systems, Chicago
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
निवड सुरू आहेफेज 3
- Northwestern University, Chicago
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
निवड सुरू आहेफेज 3
- Northwestern University, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
निवड सुरू आहेफेज 1
- Xencor Investigative Site, Chicago
- Xencor Investigative Site, Chicago
A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer
निवड सुरू आहेफेज 2
- o University of Chicago Medicine Comprehensive Cancer Center, Chicago
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
निवड सुरू आहेफेज 2
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
निवड सुरू आहे
- Northwestern University, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
निवड सुरू आहेफेज 1/2
- University of Chicago, Chicago
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
निवड सुरू आहेफेज 1/2
- Northwestern Memorial Hospital, Chicago
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
निवड सुरू आहेफेज 2
- Northwestern University, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
निवड सुरू आहेफेज 2/3
- Northwestern University, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
निवड सुरू आहेफेज 1/2
- Northwestern Memorial Hospital, Chicago
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
निवड सुरू आहेफेज 2
- University of Illinois Cancer Center, Chicago
The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk
निवड सुरू आहेस्वस्थ स्वयंसेवकांचे स्वागत आहे
- University of Illinois at Chicago, Chicago
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
निवड सुरू आहेफेज 2
- University of Chicago Medicine, Chicago
Lung Cancer Screening in High-risk Black Individuals
निवड सुरू आहेस्वस्थ स्वयंसेवकांचे स्वागत आहे
- University of Chicago, Chicago
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
निवड सुरू आहेफेज 1
- The University of Chicago Comprehensive Cancer Center, Chicago
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
निवड सुरू आहेनिरीक्षण अभ्यास
- Advocate Illinois Masonic Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
निवड सुरू आहेनिरीक्षण अभ्यास
- Massive Bio SYNERGY-AI site, Chicago
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
निवड सुरू आहेनिरीक्षण अभ्यास
- University of Chicago, Chicago
Olaparib in Patients With HRD Malignant Mesothelioma
निवड सुरू आहेफेज 2
- University of Chicago Medical Center, Chicago
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
निवड सुरू आहेनिरीक्षण अभ्यास
- Thoracic Surgery, Canning Thoracic Institute (Northwestern Memorial Hospital), Chicago
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
निवड सुरू आहेनिरीक्षण अभ्यास
- Northwestern University, Chicago
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
निवड सुरू आहेफेज 2
- Northwestern University, Chicago
इतर शहरांतील फुफ्फुसाचा कॅन्सर ट्रायल्स
- Houston, TX78 अभ्यास
- Boston, MA62 अभ्यास
- New York City, NY60 अभ्यास
- Los Angeles, CA45 अभ्यास
- Washington, DC41 अभ्यास
- Arlington, VA41 अभ्यास
- Nashville, TN40 अभ्यास
- Baltimore, MD40 अभ्यास
- St. Louis, MO39 अभ्यास
- Columbus, OH37 अभ्यास
- Philadelphia, PA36 अभ्यास
- Seattle, WA33 अभ्यास
Chicago मधील इतर अभ्यास
- नॉन-स्मॉल सेल लंग कॅन्सर61 अभ्यास
- स्तनाचा कर्करोग58 अभ्यास
- कर्करोग (सर्व प्रकार)51 अभ्यास
- मेटास्टॅटिक कर्करोग45 अभ्यास
- प्रोस्टेट कर्करोग45 अभ्यास
- स्थूलता41 अभ्यास
- अंडाशयाचा कर्करोग36 अभ्यास
- स्ट्रोक34 अभ्यास
- कोलोरॅक्टल कॅन्सर33 अभ्यास
- हृदयाची अशक्तपणा31 अभ्यास
- अतिवजन28 अभ्यास
- डोके आणि मानेचा स्क्वॅमस सेल कार्सिनोमा26 अभ्यास
ClinicalTrials.gov वरून, 5 ऑक्टो, 2026 रोजी मिळालेली माहिती. प्रत्येक अभ्यासासाठी पात्रतेचे निकष वेगळे असतात; अभ्यास संघ ठरवतो की कोण सहभागी होऊ शकते.